Literature DB >> 8683155

Fc receptor off-signal in the B cell involves apoptosis.

R F Ashman1, D Peckham, L L Stunz.   

Abstract

By linking surface Ig to the FcR Fc gamma RII on the mouse B lymphocyte surface, whole anti-Ig has been shown to block cell cycle entry and subsequent Ab production, a phenomenon called the "Fc receptor off-signal." IL-4 or blocking Ab to Fc gamma RII, present with whole anti-Ig, restores cell cycle progress to the levels observed with F(ab')2 anti-Ig. The current study demonstrates that under "off-signal" conditions with whole anti-Ig, the early entry of B cells into apoptosis was accelerated relative to medium alone or equimolar F(ab')2 anti-Ig. All reagents tested which opposed the whole-anti-Ig-induced blockade of B cell cycle entry also protected B cells from apoptosis (IL-4, PMA, dextran sulfate, and the monoclonal anti-Fc gamma RII 2.4G2). This protective effect was most evident at 4 to 12 h, waning at later times. Low dose cycloheximide partially protected B cells from whole anti-Ig-induced apoptosis, but acted as a survival factor, failing to advance B cells from G0 phase or stimulate thymidine incorporation. Additive early apoptosis-associated membrane changes were transiently seen when whole anti-Ig was combined with other apoptosis-accelerating agents (trifluoperazine, staurosporine, dexamethasone, ionomycin, high-dose cycloheximide), but hypodiploid nuclei did not show this effect. B cells from bcl-2 transgenic mice showed less apoptosis when cultured with whole anti-Ig, or with any of the other agents tested. At 4 h the bcl-2-associated reduction in hypodiploid nuclei was greater than the reduction in membrane unpacking, but by 16 h this difference was much less. These results suggest that acceleration of apoptosis contributes to the inhibition of proliferation induced by whole anti-Ig.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683155

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling.

Authors:  M J Aman; S F Walk; M E March; H P Su; D J Carver; K S Ravichandran
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 3.  Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.

Authors:  Christiane S Hampe
Journal:  Autoimmunity       Date:  2012-02-23       Impact factor: 2.815

4.  Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin.

Authors:  Martin S Zand; Thuong Vo; Tina Pellegrin; Raymond Felgar; Jane L Liesveld; Jainulabdeen J Ifthikharuddin; Camille N Abboud; Ignacio Sanz; Jennifer Huggins
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

5.  The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.

Authors:  M B Callanan; P Le Baccon; P Mossuz; S Duley; C Bastard; R Hamoudi; M J Dyer; G Klobeck; R Rimokh; J J Sotto; D Leroux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Role of Fc gamma receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi.

Authors:  J Talkington; S P Nickell
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  FcγRIIb expression in early stage chronic lymphocytic leukemia.

Authors:  Rosa Bosch; Alba Mora; Eva Puy Vicente; Gerardo Ferrer; Sonia Jansà; Rajendra Damle; Sergey Gorlatov; Kanti Rai; Emili Montserrat; Josep Nomdedeu; Marta Pratcorona; Laura Blanco; Silvana Saavedra; Ana Garrido; Albert Esquirol; Irene Garcia; Miquel Granell; Rodrigo Martino; Julio Delgado; Jorge Sierra; Nicholas Chiorazzi; Carol Moreno
Journal:  Leuk Lymphoma       Date:  2017-04-04

8.  Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth.

Authors:  Cheryl A Doughty; Blair F Bleiman; Dean J Wagner; Fay J Dufort; Jennifer M Mataraza; Mary F Roberts; Thomas C Chiles
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

Review 9.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

10.  Lipopolysaccharide protects primary B lymphocytes from apoptosis by preventing mitochondrial dysfunction and bax translocation to mitochondria.

Authors:  Vongthip Souvannavong; Christophe Lemaire; Richard Chaby
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.